Kazakhstan surrogacy: medical and donor requirements
Start with eligibility, then assess the medical pathway
For a Kazakhstan surrogacy arrangement, the important question is not simply which tests a clinic asks for. You need to separate binding statutory criteria, the Ministry of Health’s procedure rules, and any additional clinic protocol. As at , the current Family Code and Health Code, Orders No. ҚР ДСМ-272/2020 and No. ҚР ДСМ-236/2020, and the amendments effective in October 2026 are the starting points.
Check intended-parent eligibility before paying for medical screening. Since the amendment introduced by Law No. 350-VIII of 14 July 2026 took effect, a surrogacy contract may be concluded only by a married couple in which both intended parents are citizens of Kazakhstan. A medically suitable surrogate or a clinic’s willingness to start tests cannot cure an intended-parent eligibility problem. If a contract was signed, a cycle started, or a cross-border element arose before the amendment, do not assume the transition is resolved: obtain case-specific advice.
If the intended parents pass that first gate, the next questions are whether the surrogate meets the statutory profile, whether her required tests are current, whether any ART contraindication applies, and what gamete or embryo source the clinic proposes to use.
Which rules bind the clinic, and which may be clinic policy?
The Family Code governs the surrogacy contract and the statutory profile of the surrogate. The Health Code sets the statutory baseline for gamete donors. Ministry of Health orders provide detailed medical procedures, screening schedules, indications and contraindications. These are not interchangeable sources.
A clinic may request additional tests or apply a cautious protocol, but an extra requirement is not automatically statutory. Ask for the exact provision behind each claimed legal exclusion and require the clinic to distinguish binding law from its own policy or an individual medical decision.
Official sources were checked; older checklists may be obsolete.
Statutory requirements for a surrogate mother
Article 56 of the Family Code sets three core requirements: the woman must be 20–35 years old; have her own healthy child; and have satisfactory physical, mental and reproductive health confirmed by a healthcare organisation’s medical conclusion. These are legal criteria, not merely preferences of a particular clinic. Meeting them does not guarantee acceptance: the separate ART screening and contraindication rules still apply.
If the surrogate is in a registered marriage, she must provide written consent from her spouse, notarised when the surrogacy contract is concluded. The notarial rules also call for the surrogate’s original medical conclusion, an original certificate concerning the health of her child or children, and the child’s birth certificate or certificates. If she is unmarried, the notary obtains a statement to that effect and certifies the authenticity of her signature.
The clinic must issue a conclusion on the use of ART that gives complete information about the biological material used: material from the intended parents or a donor bank. One original copy is attached to the notarised surrogacy contract and retained at the place where the transaction is completed.
Medical screening: the required scope and validity windows
Order No. ҚР ДСМ-272/2020, Appendix 2, prescribes the surrogate screening scope. It is a schedule, not a generic list that can be copied between patients or cycles. Check each result’s expiry against the planned procedure date; a test that was valid at intake may be stale by transfer.
- Before each procedure: transvaginal gynaecological ultrasound, complete blood count with ESR and urinalysis. Vaginal-smear purity testing has a 10-day validity period.
- Infectious screening: hepatitis B and C tests are generally valid for 3 months; HIV and p24-antigen testing for 10 days; syphilis serology by the microprecipitation reaction for 30 days under the amendment effective 17 October 2026; Chlamydia trachomatis IgM testing and the specified PCR panel for 3 months.
- Consultations and cytology: therapist’s conclusion on health and the permissibility of IVF/pregnancy, 6 months; psychiatrist and narcologist conclusions, 12 months; cervical cytology, 12 months.
- Other laboratory tests: TSH, prolactin and testosterone, 6 months; rubella IgG/IgM once if there is no evidence of vaccination or previous disease (the rule gives a 3-month validity period); biochemical blood tests and coagulation profile, 10 days.
- Imaging and cardiac tests: breast ultrasound, abdominal and kidney ultrasound, and fluorography, 12 months; ECG, 3 months; mammography for patients older than 40, once every 2 years.
- When indicated: hysterosalpingography, laparoscopy or hysteroscopy with endometrial histology, and specified additional hormone tests. The treating specialist determines which indicated tests are necessary.
This is a category summary, not a substitute for the complete current Appendix 2. The clinic must check the actual file, including the amended syphilis test.
Contraindications and an important wording conflict
The ART rules list circumstances in which embryo transfer in a surrogacy procedure is contraindicated. These include somatic or mental conditions that contraindicate pregnancy; congenital or acquired uterine-cavity deformities; uterine tumours requiring surgery; acute inflammatory disease at any location; malignant neoplasms at any location; a history of four or more births; and an adverse obstetric history, including a uterine scar after caesarean section or conservative myomectomy, or uterine perforation.
There is also a source-language discrepancy in this item: the Russian text and the English rendering describe uterine tumours requiring surgery as benign, while the Kazakh-language text appears to describe them as malignant. This guide does not decide which wording controls; obtain a written interpretation from Kazakhstan counsel before applying this part of the list.
Do not silently resolve a potential inconsistency. Order No. 126, effective 17 October 2026, revised the general IVF contraindication rule to refer to two or more uterine scars plus documented anatomical/functional insufficiency and high risk. However, the separate surrogacy-specific list in paragraph 47 still contains the broader adverse-obstetric-history wording described above. The amendment does not expressly explain how these provisions interact. This guide therefore does not claim that one automatically overrides the other.
For a scar or prior obstetric event, request a written case-specific medical assessment and the exact provision applied. A lawyer should reconcile the current texts before advising that transfer is permitted; “the doctor approved it” does not resolve the legal wording.
Gamete donor eligibility, consent and legal status
Article 148 of the Health Code provides that a donor of gametes or reproductive-organ tissue must be a citizen of Kazakhstan aged 18–35, physically and mentally healthy, and medically-genetically examined. The statutory age range applies to gamete donors; it is not the surrogate’s 20–35 age range.
Donation is voluntary and requires the donor’s written informed consent. An oocyte donor must be informed in writing about health complications associated with the planned intervention. The donor must undergo medical-genetic screening and obtain a conclusion from a reproductive specialist or urologist-andrologist confirming that donation may proceed. If the donor is married, donation requires written consent from both spouses; use of gametes by a married recipient also requires written consent from both spouses.
The rules allow paid or unpaid donation and anonymous or non-anonymous donation. Donors do not assume parental duties toward the future child and have no right to information about the subsequent fate of their donated gametes. The birth of 10 children from one donor is a ground to stop using that donor for recipients.
The current Health Code and Order No. ҚР ДСМ-236/2020 reviewed here do not state that an oocyte donor must already have her own healthy child as a general statutory condition. A clinic may have a separate selection policy; it should not be presented as binding law without a source.
Donor screening and sperm requirements
The current donor rules require medical-genetic screening. For oocyte donors, the schedule includes blood group and Rh factor; a therapist’s assessment of health and absence of contraindications before each retrieval; psychiatric and narcological consultations annually; genetic consultation and karyotype once; and molecular testing for common inherited-disease variants such as PAH-related phenylketonuria and cystic fibrosis when indicated. The same annex also lists urinalysis, ECG, complete blood count and vaginal-smear assessment before each procedure; hepatitis B/C and HIV/p24 testing (generally valid for 3 months); biochemistry and coagulation tests (1 month); fluorography and cervical cytology (12 months); and PCR tests for chlamydia, gonorrhoea, herpes and CMV (3 months). Order No. 126 changed the syphilis entry to testing before each procedure. Check Annex 1 for the complete list and exact validity periods.
For sperm donors, the rule specifies medical examinations and quality thresholds for the sample: ejaculate volume above 1.5 ml; sperm concentration of at least 15 million/ml and total count of at least 22.5 million; progressive motility of at least 32%; morphologically normal forms of at least 4% (14% or more under strict Kruger criteria); and cryotolerance. A MAR test is performed when indicated. These are stated regulatory thresholds, not a guarantee of fertilisation or pregnancy.
Order No. 126 of September 2026 requires donor-sperm testing for hepatitis B, hepatitis C, HIV and HIV p24 antigen before cryopreservation and again at 3 and 6 months after cryopreservation. It also requires syphilis serology before each procedure in both the oocyte-donor and sperm-donor schedules. For donor-sperm insemination, only cryopreserved, quarantined donor sperm may be used, and the required repeat infectious tests after 6 months must be negative. Ask for a dated record showing results, repeat-test dates and donor code rather than relying on verbal assurances.
Can donor eggs, sperm or embryos be used in a surrogacy programme?
The Family Code expressly anticipates that the clinic’s ART conclusion will identify biological material from the intended parents or a donor bank. Donor material is therefore part of the statutory framework, but that does not mean every possible combination is authorised in every surrogacy procedure.
Paragraph 49 of Order No. ҚР ДСМ-272/2020 addresses transfer of frozen embryos of the genetic parents. It states that the surrogate is not simultaneously the egg donor and that donor oocytes, donor sperm and donor embryos are not used simultaneously in the surrogacy programme. The wording is procedure-specific and does not clearly explain every possible programme involving one or two donor sources.
Do not read this as a blanket ban on all donor material or as permission for every combination. Before signing or creating embryos, obtain a written plan naming the oocyte and sperm sources, whether an embryo already exists, the clause relied on and how the plan fits paragraph 49. If interpretation is needed, have Kazakhstani counsel check the current official text.
Documents and a practical decision matrix
Before signing or treatment, assemble a dated file containing:
- the surrogate’s original medical conclusion on physical, mental and reproductive health;
- the original certificate about the health of the surrogate’s child or children and their birth certificate(s);
- if the surrogate is married, her spouse’s notarised written consent; if unmarried, the notarial statement confirming that status;
- the intended parents’ marriage certificate;
- the clinic’s ART conclusion identifying the biological material used, attached in original to the notarised surrogacy contract;
- the intended parents’ medical conclusion on physical and mental health and the results of medical-genetic examination required by Article 57;
- dated screening results, specialist conclusions, donor code and donor/embryo records relevant to the planned procedure.
The matrix is for initial triage, not a full legal assessment.
| Situation | What it means | Next safe step |
|---|---|---|
| The intended parents are not a married couple in which both partners are citizens of Kazakhstan. | They do not meet the wording of the current statutory contract rule. | Pause before paying for the surrogacy pathway; obtain case-specific advice, including on any pre-amendment contract. |
| Surrogate is outside 20–35, has no own healthy child, or lacks the required health conclusion | A statutory condition is not met. | Do not proceed on a clinic’s informal assurance; ask for a written eligibility assessment. |
| Surrogate is married but notarised spouse consent is missing | The required document set is incomplete. | Obtain the notarised consent before contract execution. |
| Donor is outside 18–35 or lacks required health/genetic screening | The statutory donor baseline is not demonstrated. | Ask the clinic to confirm donor eligibility and provide coded screening records. |
| Four or more prior births, uterine scar or other adverse obstetric history | The surrogacy-specific ART rules list contraindication concerns; scar wording needs careful review alongside the amended general IVF rule. | Request a written medical assessment and legal reconciliation of the provisions. |
| Clinic demands an extra test or donor-selection condition | It may be a clinic protocol rather than an express statutory condition. | Ask for the exact rule, medical reason, validity period and cost in writing. |
| Proposed programme mixes donor eggs, sperm or embryos | Paragraph 49 must be applied to the actual procedure; the scope is not fully clear for every combination. | Obtain the material-source plan and written legal/medical explanation before creating or transferring embryos. |
What to do before committing to a programme
- Verify participants. Confirm that both intended parents are Kazakhstan citizens and are in a registered marriage under current law; check the surrogate’s age, own healthy child and medical conclusion.
- Request a dated clinic checklist. For each test, require the current order/annex, result date, validity period and any additional clinic policy.
- Resolve contraindications in writing. For uterine scars or adverse obstetric history, require the clinic and lawyer to reconcile paragraph 47 with the amended general IVF rule.
- Record donor sources. Check donor age, citizenship, health, consent, screening, repeat-test schedule and sample quality. The formal ART opinion should identify the oocyte, sperm and embryo sources.
- Complete notarial documents before treatment. Check the medical opinion, child health/birth records, spouse consent or unmarried statement, intended parents’ marriage certificate and ART opinion in the required form.
- Keep evidence. Save dated clinic answers, results, donor codes, contract and applicable rule versions. If no legal basis for a prohibition is given, obtain independent Kazakh legal review before payment or transfer.
Bottom line: legal eligibility, medical safety and donor-source compatibility are separate questions. A complete test file proves neither eligibility nor permission for a particular donor combination.
Primary sources (official legal text)
- [S1] Code of the Republic of Kazakhstan On Marriage (Matrimony) and Family, Articles 54–57 (current consolidated text)
- [S2] Code of the Republic of Kazakhstan On Public Health and Healthcare System, Articles 146–148
- [S3] Ministry of Health Order No. ҚР ДСМ-272/2020, Rules and Conditions for Assisted Reproductive Methods and Technologies
- [S4] Ministry of Health Order No. ҚР ДСМ-236/2020, Rules and Conditions for Gamete and Reproductive-Organ-Tissue Donation
- [S5] Acting Minister of Health Order No. 126 of 30 September 2026, amendments to healthcare orders (effective from 17 October 2026)
- [S6] Rules for Notarial Acts, paragraphs 214–216 (official government publication)
- [S7] Law of the Republic of Kazakhstan of 14 July 2026 No. 350-VIII ZRK, amending certain legislative acts on public administration and local self-government (surrogacy eligibility restriction)
- [S8] Kazakh-language text of Order No. ҚР ДСМ-272/2020, paragraph 47 (Adilet comparison view)
